Cargando…

Changes in serum transforming growth factor-β1 levels in chronic hepatitis C patients under antiviral therapy

BACKGROUND: Several cytokines including transforming growth factor (TGF)-β1 have been suggested to be involved in the pathogenesis of fibrosis in chronic hepatitis C. We examined the changes of TGF-β1 serum levels and their predictive value in patients with chronic hepatitis C under antiviral therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotsiri, Ioanna, Hadziyannis, Emilia, Georgiou, Anastasia, Papageorgiou, Maria-Vasiliki, Vlachogiannakos, Ioannis, Papatheodoridis, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700851/ https://www.ncbi.nlm.nih.gov/pubmed/26752952

Ejemplares similares

Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2017)

Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B
por: Laras, Andreas, et al.
Publicado: (2022)

Serum zonulin levels in patients with liver cirrhosis: Prognostic implications
por: Voulgaris, Theodoros A, et al.
Publicado: (2021)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
por: Varbobitis, Ioannis, et al.
Publicado: (2016)

Validation of cutoffs for skeletal muscle mass index based on computed tomography analysis against dual energy X-ray absorptiometry in patients with cirrhosis: the KIRRHOS study
por: Georgiou, Alexandra, et al.
Publicado: (2020)

Significance of the (13)C-caffeine breath test for patients with cirrhosis
por: Konstantinou, Dimitrios, et al.
Publicado: (2014)

Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease
por: Bamias, Giorgos, et al.
Publicado: (2016)

Is HCV core antigen a reliable marker of viral load? An evaluation of HCV core antigen automated immunoassay
por: Hadziyannis, Emilia, et al.
Publicado: (2013)

Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2011)

Efficacy and safety of new direct-acting antivirals in kidney transplant recipients with chronic hepatitis C: a single-center study
por: Darema, Maria, et al.
Publicado: (2020)

Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D
por: Konstantinides, Polydoros, et al.
Publicado: (2018)

The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
por: Cholongitas, Evangelos, et al.
Publicado: (2015)

The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking
por: Kanellopoulou, Theoni, et al.
Publicado: (2016)

The Lyon Consensus Criteria for GERD Diagnosis in a Greek Population: The Clinical Impact and Changes in GERD Diagnosis in a Real-World, Retrospective Study
por: Voulgaris, Theodoros, et al.
Publicado: (2022)

Efficacy of citalopram or amitriptyline versus no treatment in patients with functional chest pain
por: Voulgaris, Theodoros, et al.
Publicado: (2023)

Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
por: Gountas, Ilias, et al.
Publicado: (2019)

Propofol or sevoflurane anaesthesia does not affect hepatic integrity as assessed by the M30 & M65 cell death markers & liver enzymes
por: Chondrogiannis, Konstantinos, et al.
Publicado: (2014)

Clinical Characteristics, Spontaneous Clearance and Treatment Outcome of Acute Hepatitis C: A Single Tertiary Center Experience
por: Deutsch, Melanie, et al.
Publicado: (2013)

Update on Hepatitis B Virus Infection: Focus on Treatment
por: Hadziyannis, Stephanos J.
Publicado: (2014)

Platelet activation and hypercoagulability in patients with early primary biliary cholangitis compared with healthy controls
por: Vlachogiannakos, Jiannis, et al.
Publicado: (2021)

Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
por: Kostas, Athanasios, et al.
Publicado: (2017)

High prevalence of asymptomatic peptic ulcers diagnosed during screening endoscopy in patients with cirrhosis
por: Voulgaris, Theodoros, et al.
Publicado: (2019)

Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis
por: Kranidioti, Hariklia, et al.
Publicado: (2018)

Viral Biomarkers in Chronic HBeAg Negative HBV Infection
por: Hadziyannis, Emilia, et al.
Publicado: (2018)

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
por: Tampaki, Maria, et al.
Publicado: (2020)

The role of entecavir in the treatment of chronic hepatitis B
por: Dimou, Evangelini, et al.
Publicado: (2007)

Sofosbuvir: a novel oral agent for chronic hepatitis C
por: Cholongitas, Evangelos, et al.
Publicado: (2014)

Increased Frequency of Peripheral B and T Cells Expressing Granulocyte Monocyte Colony-Stimulating Factor in Rheumatoid Arthritis Patients
por: Makris, Anastasia, et al.
Publicado: (2018)

Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
por: Papatheodoridi, Margarita, et al.
Publicado: (2020)

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

Active and Intelligent Packaging for Enhancing Modified Atmospheres and Monitoring Quality and Shelf Life of Packed Gilthead Seabream Fillets at Isothermal and Variable Temperature Conditions
por: Katsouli, Maria, et al.
Publicado: (2022)

Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis
por: Dalekos, George N., et al.
Publicado: (2019)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
por: Bousali, Maria, et al.
Publicado: (2021)

The Effect of Antiviral Therapy on Serum Cholesterol Levels in Chronic Hepatitis C
por: Jang, Eun Sun, et al.
Publicado: (2011)

The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C
por: Batsaikhan, Batbold, et al.
Publicado: (2018)

Viral Infections and Schizophrenia: A Comprehensive Review
por: Kotsiri, Ioanna, et al.
Publicado: (2023)

A Novel Immunological Assay for Hepcidin Quantification in Human Serum
por: Koliaraki, Vasiliki, et al.
Publicado: (2009)

Aiming towards hepatitis C virus elimination in Greece
por: Papatheodoridis, George V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d8vngui27gtkdler23opj3np2h